In a patient who ingested 8,500 mg acetaminophen over 20 hours, weighs 85 kg, and has normal liver function tests, should N‑acetylcysteine be started in the emergency department?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Should You Start NAC in This Patient?

Yes, you should start NAC immediately in this patient. This is a repeated supratherapeutic ingestion (8,500 mg over 20 hours) that exceeds the threshold requiring treatment, and the Rumack-Matthew nomogram does not apply to this scenario 1, 2.

Why This is a Repeated Supratherapeutic Ingestion (RSI)

This patient ingested 8,500 mg acetaminophen over 20 hours, which represents:

  • 100 mg/kg per 24-hour period (8,500 mg ÷ 85 kg = 100 mg/kg)
  • Multiple ingestions over a period greater than 8 hours

This pattern defines a repeated supratherapeutic ingestion, not an acute single overdose 1, 2.

Treatment Threshold for RSI

The FDA label and guidelines are clear: For repeated supratherapeutic ingestions, you should initiate NAC if the patient ingested 2, 3:

  • ≥10 g OR 200 mg/kg (whichever is less) during a single 24-hour period, OR
  • ≥6 g OR 150 mg/kg (whichever is less) per 24-hour period for 48 hours or longer

Your patient ingested 8,500 mg (8.5 g), which exceeds the 6 g threshold for repeated ingestions over an extended period 3.

Critical Pitfall: The Nomogram Does NOT Apply Here

Do not attempt to use the Rumack-Matthew nomogram for this patient 1, 2. The nomogram is only valid for:

  • Single acute ingestions
  • Known time of ingestion
  • Acetaminophen level drawn 4-24 hours post-ingestion

For repeated supratherapeutic ingestions, the nomogram cannot risk-stratify patients because acetaminophen metabolism and hepatotoxicity kinetics differ fundamentally from acute overdose 1, 2.

Why Normal LFTs Don't Change Management

Normal liver function tests at presentation do not exclude the need for NAC in this scenario:

  • Hepatotoxicity from repeated ingestions can develop with delayed presentation
  • Studies show approximately 30% of acetaminophen overdose admissions involve repeated supratherapeutic ingestions, and these patients may have worse prognosis than acute overdoses 1
  • The protective window for NAC is ideally within 8-10 hours, but benefit extends to 24 hours and beyond 1, 4

Immediate Actions in the ED

  1. Start NAC loading dose immediately (150 mg/kg IV over 1 hour for the standard 21-hour protocol) 2

  2. Obtain acetaminophen concentration to guide continued treatment, though the level won't determine whether to start NAC—you've already made that decision based on ingested dose 2

  3. Check baseline labs: AST, ALT, INR, creatinine, and repeat every 12-24 hours 1

  4. Continue full NAC protocol (300 mg/kg total over 21 hours) unless stopping criteria are met 2

Additional Considerations for Lower Threshold

Some experts recommend even lower thresholds (4 g or 100 mg/kg per day) for patients with risk factors including 1, 3:

  • Chronic alcoholism
  • Prolonged fasting/malnutrition
  • Enzyme-inducing medications (e.g., isoniazid)

Your patient is right at the 100 mg/kg threshold, making NAC initiation even more justified if any risk factors are present.

Evidence Quality Note

The ACEP Clinical Policy provides Level B recommendations (moderate clinical certainty) for NAC administration based on risk stratification, but these apply to acute overdoses using the nomogram 1. For repeated supratherapeutic ingestions, the FDA label and consensus guidelines provide the framework, supported by case series showing worse outcomes in this population 1, 2.

Bottom line: Start NAC now. This is a repeated supratherapeutic ingestion exceeding treatment thresholds, normal LFTs don't exclude toxicity risk, and the nomogram doesn't apply to this ingestion pattern.

Related Questions

In a 78‑kg patient with no risk factors who ingested 5 g of paracetamol (acetaminophen) over a single 24‑hour period, what is the risk of acute toxicity and what management is recommended?
In urgent care, can I manage a ~20‑year‑old woman who accidentally ingested five Excedrin (acetaminophen/aspirin/caffeine) tablets a few hours ago and has a history of autoimmune hepatitis?
In a 20-year-old female who ingested 9.8 g of paracetamol within 2 hours, what is the appropriate management?
In a 28-year-old male with no comorbidities who ingested a single dose of three 650 mg tablets of paracetamol after intermittent alcohol consumption over the preceding three days, how should he be managed?
What is the risk of acute hepatic failure after ingesting 16 g of paracetamol (acetaminophen) in the first 24 hours followed by 12 g in the next 24 hours?
Should meropenem be replaced with ceftazidime‑avibactam plus aztreonam in a 27‑year‑old male with severe meningoencephalitis, recurrent seizures, Glasgow Coma Scale 6, persistent leptomeningeal enhancement, marked leukocytosis and elevated procalcitonin who is already receiving vancomycin, dexamethasone, mannitol and empirical four‑drug anti‑tubercular therapy?
Which topical antibiotic is recommended for treating a hordeolum (stye)?
For a patient with atrial fibrillation with rapid ventricular response on an amiodarone infusion, when should I transition to oral amiodarone, and how should I manage apixaban (Eliquis) when the patient has low hemoglobin?
What are the contraindications to using carvedilol in an elderly patient with asthma?
What is PAX7 and how is it used clinically to diagnose rhabdomyosarcoma and assess muscle regeneration?
What renal tubular disorders present in adolescents, and what are their typical clinical features, diagnostic workup, and first‑ and second‑line treatments?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.